awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34960458-3E1237FF-F61B-487E-8B36-72CF59F587BB
Q34960458-3E1237FF-F61B-487E-8B36-72CF59F587BB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34960458-3E1237FF-F61B-487E-8B36-72CF59F587BB
Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.
P2860
Q34960458-3E1237FF-F61B-487E-8B36-72CF59F587BB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34960458-3E1237FF-F61B-487E-8B36-72CF59F587BB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f5abeb6c0e24072fe23a47fe6944afbf6d0b8684
P2860
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.